Clinical trials
Phase 3 Pulmonary Arterial Hypertension trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| United Therapeutics | 5 |
| Actelion | 3 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2 |
| Bayer | 2 |
| Biogen | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| GB002, Inc. | 1 |
| Gilead Sciences | 1 |
| Gossamer Bio USA, Inc. | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 22 |
| Hypertension, Pulmonary | 9 |
| Hypertension | 3 |
| Cardiovascular Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Lung Diseases | 2 |
| Respiratory Tract Diseases | 2 |
| Vascular Diseases | 2 |
| Anemia, Sickle Cell | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.